Physician profile
Adam Buzzerd
NPI 1083682579
$1,869.20
in general payments reported to CMS, 2019-2025
9 companies · $495 in 2025
The $495 reported for 2025 was more than what 80% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $322 · 2022: $188 · 2023: $434 · 2024: $430 · 2025: $495.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,358.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $1,152.92 | 2021-2025 | Vasoview Hemopro 2, Vasoview Hemopro 2, Heartstring III Proximal Seal |
| Atricure, INC. | $347.29 | 2024-2025 | Atriclip Laa Exclusion System, Atricure Cryoice Cryosphere Cryoablation System, Synergy Ablation System |
| Dilon Technologies, INC. | $112.89 | 2025 | Hemoblast Bellows |
| Zimmer Biomet Holdings, INC. | $105.92 | 2021-2023 | Sternalock 360 System |
| Ethicon US, LLC | $56.92 | 2025 | Surgiflo Hemostatic Matrix, Vistaseal |
| Convatec INC. | $30.03 | 2024 | |
| Medtronic, INC. | $25.51 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.35 | 2023 | Lifevest |
| Edwards Lifesciences Corporation | $13.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Buzzerd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.